France· FR:65023242
ZYPADHERA 405 mg, poudre et solvant pour suspension injectable à libération prolongée
A medicinal product containing olanzapine (pamoate d') monohydraté, registered in France by CHEPLAPHARM REGISTRATION (ALLEMAGNE).
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- OLANZAPINE (PAMOATE D') MONOHYDRATÉ
- Manufacturer
- CHEPLAPHARM REGISTRATION (ALLEMAGNE)
- Country
- France (FR)
- ATC code
- —
- Reimbursed
- No
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 1
- cip1334009574693991 flacon(s) en verre - 1 flacon(s) en verre de 3 ml avec seringue(s) avec aiguille(s)
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Olanzapine (pamoate d') monohydraté in 18 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandZYPADHERACheplapharm Registration GmbH
- IrelandZypadhera 405 mg powder and solvent for prolonged release suspension for injectionCheplapharm Registration GmbH
- NetherlandsZypadhera 405 mg, poeder en oplosmiddel voor suspensie voor injectie, met verlengde afgifteCheplapharm Registration GmbH
- CzechiaEGOLANZAEgis Pharmaceuticals PLC, Budapešť
- United KingdomArkolamyl 10mg orodispersible tabletsViatris UK Healthcare Ltd
- United StatesolanzapineBionpharma Inc.
- SpainARENBIL 10 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFGNeuraxpharm Spain S.L.U.
- PolandAnzorinOrion Corporation
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Aedon, Olanzapin +pharma
- Belgium · Olanzapine, Olanzapine Ab
- Bulgaria · Oлфрекс, Еголанза
- Cyprus · Bloonis, Lapozan
- Czechia · Egolanza, Nykob
- Germany · Olanzapin 1 A Pharma, Olanzapin Abz
- Denmark · Farpenta, Kynapine Odt
- Estonia · Farpenta, Olanzapin Actavis
- Spain · Arenbil, Arenbil Flas
- Finland · Olanzapin Orion, Olanzapin Ratiopharm
- United Kingdom (Northern Ireland) · Olanzapine Accord, Olanzapine Bristol Laboratories
- Greece · Bloonis, Caprilon Od
- Croatia · Olandix, Olanzalux
- Hungary · Egolanza, Olpinat
- Ireland · Olanzapine Accord, Olanzapine Accord Healthcare Ireland
- Iceland · Olanzapin Actavis, Olanzapine Teva
- Italy · Farpenta, Lazapir
- Liechtenstein · Olanzapine Teva, Olanzapine Viatris
- Lithuania · Olanzapin Actavis, Olanzapine Accord
- Luxembourg · Olanzapine Eg, Olanzapine Instant Eg
- Latvia · Olanzapine Accord
- Malta · Olancer, Olanzapine Aurobindo
- Netherlands · Olanzapine Accord, Olanzapine Aurobindo
- Norway · Olanzapine Accord, Olanzapine Teva
- Poland · Egolanza, Olanzapina Viatris
- Portugal · Olanzapina Alter, Olanzapina Aurobindo
- Romania · Olanzapină Arena, Olanzapina Aurobindo
- Sweden · Olanzapin Actavis, Olanzapin Sandoz
- Slovenia · Zolrix
- Slovakia · Olanzapin Actavis, Olanzapin Viatris
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/71c20429-e660-4c49-8bcc-6fc5ddbd3fe6 GET /v1/drugs/71c20429-e660-4c49-8bcc-6fc5ddbd3fe6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "65023242",
"date_amm": "2008-11-19",
"type_amm": "Procédure centralisée",
"numero_ue": "EU/1/08/479",
"substance": "OLANZAPINE (PAMOATE D') MONOHYDRATÉ",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "poudre et solvant pour suspension injectable à libération prolongée",
"voies_administration": "intramusculaire",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about olanzapine (pamoate d') monohydraté.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.